O	0	7	Cloning	Cloning	NN	B-NP
O	8	11	and	and	CC	I-NP
O	12	28	characterization	characterization	NN	I-NP
O	29	31	of	of	IN	B-PP
O	32	35	the	the	DT	B-NP
O	36	42	latent	latent	JJ	I-NP
O	43	51	membrane	membrane	NN	I-NP
O	52	59	protein	protein	NN	I-NP
O	60	61	(	(	(	O
O	61	64	LMP	LMP	NN	B-NP
O	64	65	)	)	)	O
O	66	68	of	of	IN	B-PP
O	69	70	a	a	DT	B-NP
O	71	79	specific	specific	JJ	I-NP
O	80	87	Epstein	Epstein	NNP	I-NP
O	87	88	-	-	HYPH	I-NP
O	88	92	Barr	Barr	NNP	I-NP
O	93	98	virus	virus	NN	I-NP
O	99	106	variant	variant	NN	I-NP
O	107	114	derived	derive	VBN	B-VP
O	115	119	from	from	IN	B-PP
O	120	123	the	the	DT	B-NP
B-Cancer	124	138	nasopharyngeal	nasopharyngeal	JJ	I-NP
I-Cancer	139	148	carcinoma	carcinoma	NN	I-NP
O	149	151	in	in	IN	B-PP
O	152	155	the	the	DT	B-NP
O	156	165	Taiwanese	Taiwanese	JJ	I-NP
O	166	176	population	population	NN	I-NP
O	176	177	.	.	.	O

O	179	180	A	A	DT	B-NP
O	181	184	DNA	DNA	NN	I-NP
O	185	193	fragment	fragment	NN	I-NP
O	194	204	containing	contain	VBG	B-VP
O	205	212	Epstein	Epstein	NNP	B-NP
O	212	213	-	-	HYPH	B-NP
O	213	217	Barr	Barr	NNP	I-NP
O	218	223	virus	virus	NN	I-NP
O	224	225	(	(	(	O
O	225	228	EBV	EBV	NN	B-NP
O	228	229	)	)	)	O
O	230	238	terminal	terminal	JJ	B-NP
O	239	247	fragment	fragment	NN	I-NP
O	248	256	sequence	sequence	NN	I-NP
O	257	260	was	be	VBD	B-VP
O	261	269	obtained	obtain	VBN	I-VP
O	270	274	from	from	IN	B-PP
O	275	276	a	a	DT	B-NP
O	277	284	genomic	genomic	JJ	I-NP
O	285	292	library	library	NN	I-NP
O	293	295	of	of	IN	B-PP
B-Cancer	296	310	nasopharyngeal	nasopharyngeal	JJ	B-NP
I-Cancer	311	320	carcinoma	carcinoma	NN	I-NP
O	321	322	(	(	(	O
B-Cancer	322	325	NPC	NPC	NN	B-NP
O	325	326	)	)	)	O
O	326	327	.	.	.	O

O	328	331	One	One	CD	B-NP
O	332	334	of	of	IN	B-PP
O	335	338	the	the	DT	B-NP
O	339	345	clones	clone	NNS	I-NP
O	346	347	(	(	(	O
O	347	352	clone	clone	NN	B-NP
O	353	357	1510	1510	CD	I-NP
O	357	358	)	)	)	O
O	359	368	contained	contain	VBD	B-VP
O	369	372	the	the	DT	B-NP
O	373	377	gene	gene	NN	I-NP
O	378	386	encoding	encode	VBG	B-VP
O	387	393	latent	latent	JJ	B-NP
O	394	402	membrane	membrane	NN	I-NP
O	403	410	protein	protein	NN	I-NP
O	411	412	(	(	(	O
O	412	415	LMP	LMP	NN	B-NP
O	415	416	)	)	)	O
O	416	417	.	.	.	O

O	418	426	Sequence	Sequence	NN	B-NP
O	427	435	analysis	analysis	NN	I-NP
O	436	444	revealed	reveal	VBD	B-VP
O	445	449	that	that	IN	B-SBAR
O	450	454	this	this	DT	B-NP
O	455	459	gene	gene	NN	I-NP
O	460	463	had	have	VBD	B-VP
O	464	466	95	95	CD	B-NP
O	466	467	%	%	NN	I-NP
O	468	476	homology	homology	NN	I-NP
O	477	481	with	with	IN	B-PP
O	482	485	the	the	DT	B-NP
O	486	489	LMP	LMP	NN	I-NP
O	490	498	sequence	sequence	NN	I-NP
O	499	501	of	of	IN	B-PP
O	502	505	the	the	DT	B-NP
O	506	509	B95	B95	NN	I-NP
O	509	510	-	-	HYPH	I-NP
O	510	511	8	8	CD	I-NP
O	512	518	strain	strain	NN	I-NP
O	518	519	.	.	.	O

O	520	525	Among	Among	IN	B-PP
O	526	529	the	the	DT	B-NP
O	530	538	sequence	sequence	NN	I-NP
O	539	549	variations	variation	NNS	I-NP
O	549	550	,	,	,	O
O	551	556	there	there	EX	B-NP
O	557	560	was	be	VBD	B-VP
O	561	562	a	a	DT	B-NP
O	563	569	change	change	NN	I-NP
O	570	574	from	from	IN	B-PP
O	575	576	G	G	NN	B-NP
O	577	579	to	to	TO	B-PP
O	580	581	T	T	NN	B-NP
O	582	584	at	at	IN	B-PP
O	585	595	nucleotide	nucleotide	NN	B-NP
O	596	604	position	position	NN	I-NP
O	605	608	169	169	CD	I-NP
O	608	609	,	,	,	I-NP
O	609	612	426	426	CD	I-NP
O	612	613	,	,	,	O
O	614	623	resulting	result	VBG	B-VP
O	624	626	in	in	IN	B-PP
O	627	630	the	the	DT	B-NP
O	631	635	loss	loss	NN	I-NP
O	636	638	of	of	IN	B-PP
O	639	641	an	an	DT	B-NP
O	642	646	XhoI	XhoI	NN	I-NP
O	647	651	site	site	NN	I-NP
O	652	654	in	in	IN	B-PP
O	655	659	exon	exon	NN	B-NP
O	660	661	1	1	CD	I-NP
O	662	664	of	of	IN	B-PP
O	665	668	the	the	DT	B-NP
O	669	672	LMP	LMP	NN	I-NP
O	673	677	gene	gene	NN	I-NP
O	677	678	.	.	.	O

O	679	680	A	A	DT	B-NP
O	681	685	pair	pair	NN	I-NP
O	686	688	of	of	IN	B-PP
O	689	696	primers	primer	NNS	B-NP
O	697	707	bracketing	bracket	VBG	B-VP
O	708	711	the	the	DT	B-NP
O	712	716	XhoI	XhoI	NN	I-NP
O	717	721	site	site	NN	I-NP
O	722	726	were	be	VBD	B-VP
O	727	735	designed	design	VBN	I-VP
O	736	738	to	to	TO	B-VP
O	739	749	synthesize	synthesize	VB	I-VP
O	750	753	the	the	DT	B-NP
O	754	757	EBV	EBV	NN	I-NP
O	758	761	DNA	DNA	NN	I-NP
O	762	770	fragment	fragment	NN	I-NP
O	771	775	from	from	IN	B-PP
O	776	787	nucleotides	nucleotide	NNS	B-NP
O	788	791	169	169	CD	I-NP
O	791	792	,	,	,	I-NP
O	792	795	081	081	CD	I-NP
O	795	796	-	-	HYPH	B-NP
O	796	799	169	169	CD	I-NP
O	799	800	,	,	,	I-NP
O	800	803	577	577	CD	I-NP
O	804	806	by	by	IN	B-PP
O	807	812	using	use	VBG	B-VP
O	813	816	the	the	DT	B-NP
O	817	827	polymerase	polymerase	NN	I-NP
O	828	833	chain	chain	NN	I-NP
O	834	842	reaction	reaction	NN	I-NP
O	843	844	(	(	(	O
O	844	847	PCR	PCR	NN	B-NP
O	847	848	)	)	)	O
O	849	855	method	method	NN	B-NP
O	855	856	.	.	.	O

O	857	860	The	The	DT	B-NP
O	861	864	PCR	PCR	NN	I-NP
O	865	873	products	product	NNS	I-NP
O	874	878	were	be	VBD	B-VP
O	879	883	then	then	RB	B-ADJP
O	884	891	subject	subject	JJ	I-ADJP
O	892	894	to	to	TO	B-PP
O	895	899	XhoI	XhoI	NN	B-NP
O	900	909	digestion	digestion	NN	I-NP
O	910	913	and	and	CC	B-PP
O	914	916	to	to	TO	B-PP
O	917	920	DNA	DNA	NN	B-NP
O	921	931	sequencing	sequencing	NN	I-NP
O	932	940	analysis	analysis	NN	I-NP
O	940	941	.	.	.	O

O	942	946	This	This	DT	B-NP
O	947	958	restriction	restriction	NN	I-NP
O	959	965	enzyme	enzyme	NN	I-NP
O	966	970	site	site	NN	I-NP
O	971	983	polymorphism	polymorphism	NN	I-NP
O	984	989	along	along	IN	B-PP
O	990	994	with	with	IN	B-PP
O	995	998	the	the	DT	B-NP
O	999	1007	sequence	sequence	NN	I-NP
O	1008	1018	variations	variation	NNS	I-NP
O	1019	1023	were	be	VBD	B-VP
O	1024	1028	also	also	RB	I-VP
O	1029	1037	observed	observe	VBN	I-VP
O	1038	1040	in	in	IN	B-PP
O	1041	1043	50	50	CD	B-NP
B-Tissue	1044	1050	biopsy	biopsy	NN	I-NP
I-Tissue	1051	1058	tissues	tissue	NNS	I-NP
O	1059	1061	as	as	RB	B-CONJP
O	1062	1066	well	well	RB	I-CONJP
O	1067	1069	as	as	IN	I-CONJP
O	1070	1072	in	in	IN	B-PP
O	1073	1076	the	the	DT	B-NP
B-Organism_subdivision	1077	1083	throat	throat	NN	I-NP
O	1084	1092	washings	washing	NNS	I-NP
O	1093	1095	of	of	IN	B-PP
O	1096	1097	6	6	CD	B-NP
O	1098	1101	out	out	IN	I-NP
O	1102	1104	of	of	IN	I-NP
O	1105	1107	20	20	CD	I-NP
O	1108	1115	healthy	healthy	JJ	I-NP
O	1116	1127	individuals	individual	NNS	I-NP
O	1128	1132	that	that	IN	B-NP
O	1133	1135	we	we	PRP	B-NP
O	1136	1144	examined	examine	VBD	B-VP
O	1144	1145	,	,	,	O
O	1146	1156	indicating	indicate	VBG	B-VP
O	1157	1161	that	that	IN	B-SBAR
O	1162	1165	the	the	DT	B-NP
O	1166	1169	EBV	EBV	NN	I-NP
O	1170	1176	strain	strain	NN	I-NP
O	1177	1190	predominantly	predominantly	RB	B-VP
O	1191	1199	existing	exist	VBG	I-VP
O	1200	1202	in	in	IN	B-PP
O	1203	1208	these	these	DT	B-NP
B-Tissue	1209	1215	biopsy	biopsy	NN	I-NP
I-Tissue	1216	1223	tissues	tissue	NNS	I-NP
O	1224	1227	was	be	VBD	B-VP
O	1228	1237	different	different	JJ	B-ADJP
O	1238	1242	from	from	IN	B-PP
O	1243	1250	strains	strain	NNS	B-NP
O	1251	1253	of	of	IN	B-PP
O	1254	1257	B95	B95	NN	B-NP
O	1257	1258	-	-	HYPH	B-NP
O	1258	1259	8	8	CD	I-NP
O	1259	1260	,	,	,	I-NP
O	1261	1267	Jijoye	Jijoye	NN	I-NP
O	1268	1270	or	or	CC	O
O	1271	1275	nude	nude	JJ	B-NP
O	1276	1281	mouse	mouse	NN	I-NP
O	1282	1290	passaged	passage	VBN	B-VP
B-Cell	1291	1296	cells	cell	NNS	B-NP
O	1297	1298	(	(	(	O
B-Cell	1298	1301	C15	C15	NN	B-NP
O	1301	1302	)	)	)	O
O	1303	1307	with	with	IN	B-PP
O	1308	1310	an	an	DT	B-NP
O	1311	1318	African	African	JJ	I-NP
O	1319	1325	origin	origin	NN	I-NP
O	1325	1326	,	,	,	O
O	1327	1330	but	but	CC	O
O	1331	1338	closely	closely	RB	B-VP
O	1339	1348	resembled	resemble	VBD	I-VP
O	1349	1354	other	other	JJ	B-NP
O	1355	1359	nude	nude	JJ	I-NP
O	1360	1365	mouse	mouse	NN	I-NP
O	1366	1374	passaged	passage	VBD	B-VP
B-Cell	1375	1378	CAO	CAO	NN	B-NP
I-Cell	1379	1384	cells	cell	NNS	I-NP
O	1385	1390	which	which	WDT	B-NP
O	1391	1395	were	be	VBD	B-VP
O	1396	1406	originally	originally	RB	I-VP
O	1407	1414	derived	derive	VBN	I-VP
O	1415	1419	from	from	IN	B-PP
O	1420	1425	China	China	NNP	B-NP
O	1425	1426	.	.	.	O

B-Cell	1427	1431	Balb	Balb	NN	B-NP
I-Cell	1431	1432	/	/	SYM	I-NP
I-Cell	1432	1433	c	c	NN	I-NP
I-Cell	1434	1437	3T3	3T3	NN	I-NP
I-Cell	1438	1443	cells	cell	NNS	I-NP
O	1444	1452	carrying	carry	VBG	B-VP
O	1453	1457	this	this	DT	B-NP
B-Cancer	1458	1461	NPC	NPC	NN	I-NP
O	1461	1462	-	-	HYPH	B-NP
O	1462	1465	LMP	LMP	NN	I-NP
O	1466	1470	gene	gene	NN	I-NP
O	1471	1477	showed	show	VBD	B-VP
O	1478	1479	a	a	DT	B-NP
O	1480	1491	transformed	transform	VBN	I-NP
B-Cell	1492	1496	cell	cell	NN	I-NP
O	1497	1507	morphology	morphology	NN	I-NP
O	1508	1511	and	and	CC	O
O	1512	1516	were	be	VBD	B-VP
O	1517	1528	tumorigenic	tumorigenic	JJ	B-ADJP
O	1529	1531	in	in	IN	B-PP
O	1532	1536	nude	nude	JJ	B-NP
O	1537	1541	mice	mouse	NNS	I-NP
O	1541	1542	.	.	.	O

O	1543	1546	The	The	DT	B-NP
O	1547	1559	relationship	relationship	NN	I-NP
O	1560	1567	between	between	IN	B-PP
O	1568	1572	this	this	DT	B-NP
O	1573	1579	unique	unique	JJ	I-NP
O	1580	1584	type	type	NN	I-NP
O	1585	1587	of	of	IN	B-PP
O	1588	1591	EBV	EBV	NN	B-NP
O	1592	1595	and	and	CC	I-NP
B-Cancer	1596	1599	NPC	NPC	NN	I-NP
O	1600	1603	has	have	VBZ	B-VP
O	1604	1607	yet	yet	RB	I-VP
O	1608	1610	to	to	TO	I-VP
O	1611	1613	be	be	VB	I-VP
O	1614	1625	established	establish	VBN	I-VP
O	1625	1626	.	.	.	O

